Breathe in. Breathe out. Think forward.
Pulmotree is a young, dynamic life-science startup based in Munich, Germany. Driven by new ideas, we are forward-thinking in patient treatments – and with many years of expertise, the entire industry.
Reduction of clinical risks
Reducing risks with the Pulmotree Kolibri by adherence monitoring and inhalation technique analysis.
Development approach
Highly efficient drug delivery and maximum support for patient and caregiver. The Pulmotree Kolibri is the evolution of aerosol therapy.
Exclusivity in every detail
Adding value and protection with our innovative key & lock technology.
Our partnering approach
With the Pulmotree Kolibri platform together and at eye level for optimal aerosol therapy.
Where we might run into each other
22. May – 23. May 2025, Munich, Germany
Global Pulmonary Health: Inhalation & Respiratory Conference 2025
Speaker: Ulf Krueger
Title: “Connected health beyond adherence monitoring — Meaningful use of data for the success of clinical development ”
22. June – 25. June 2025, Washington DC, USA
ISAM Congress 2025
Delegates: Ulf Krueger and Carolina Dantas
8. October – 9. October 2025, Barcelona, Spain
6th Annual Inhalation and Respiratory Drug Delivery Conference
Conference Chairman and Speaker: Ulf Krueger
5. November – 6. November 2025, San Francisco, USA
RESCON USA SUMMIT 2025
Inhalation & RESpiratory Drug Delivery | CONnected Devices
Speaker: Ulf Krueger
10. December – 12. December 2025, Edinburgh, Scotland
Drug Delivery to the Lungs Conference 2025
Delegates: Ulf Krueger and Carolina Dantas
Our Sponsors and Investors
WIPANO
BUNDESMINISTERIUM FÜR WIRTSCHAFT UND ENERGIE
BAYERISCHE BETEILIGUNGSGESELLSCHAFT